Related Experiment Videos
Basal cell hyperplasia of the prostate
American Journal of Clinical Pathology
|December 1, 1983
Summary
Basal cell hyperplasia of the prostate is a rare, benign condition often mistaken for cancer. Review of 13 cases confirms its distinct features, differentiating it from prostate adenocarcinoma.
Area of Science:
- Urology
- Pathology
- Oncology
Background:
- Basal cell hyperplasia (BCH) is a rare prostate lesion.
- It is frequently misdiagnosed as prostate adenocarcinoma.
- BCH often co-occurs with benign prostatic hyperplasia (BPH).
Purpose of the Study:
- To review histologic and ultrastructural features of BCH.
- To differentiate BCH from prostate adenocarcinoma.
- To identify key diagnostic criteria for BCH.
Main Methods:
- Histologic review of 13 BCH cases.
- Electron microscopy of formalin-fixed tissues.
- Comparison of BCH features with typical glandular hyperplasia and adenocarcinoma.
Main Results:
- BCH presents as nests of uniform small cells with scant cytoplasm.
- Lesions show nodular configurations, often merging with BPH nodules.
- Absence of nuclear atypia or pleomorphism distinguishes BCH from carcinoma.
- Electron microscopy revealed elongated cells with desmosomes.
- Two patients had synchronous, unrelated prostate carcinoma foci.
Conclusions:
- Basal cell hyperplasia has distinct architectural and cytologic features.
- These features differentiate it from prostate adenocarcinoma.
- Accurate diagnosis of BCH is crucial to avoid misclassification as cancer.